|
- Natera Portal Hub
Visit the appropriate Natera™ portal to check on results, schedule conversations with genetic counselors, place orders, or make payments
- Natera: A global leader in cell-free DNA testing
Dedicated to oncology, women’s health, and organ health Natera’s cell-free DNA tests help protect health and inform more personalized decisions about care
- Natera - Unified patient portal
By continuing, you are accepting our Terms of Use and Privacy Policy
- Natera - Wikipedia
Natera, Inc is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health
- Natera, Inc. | Natera Announces Broad Clinical Launch of Ultra . . .
Extensive pan-cancer validation data from over 3,000 plasma samples to be presented at ASCO Natera, Inc (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that its ultra-sensitive Signatera Genome assay is now broadly available to physicians in the United States
- Natera Announces Broad Clinical Launch of Ultra-Sensitive Signatera . . .
AUSTIN, Texas, April 24, 2025--Natera, Inc (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that its ultra-sensitive Signatera Genome assay is now
- About Us | Natera
Natera ™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives
- Natera - Patient service
Access patient services for health-related testing, results, and personalized care options provided by Natera
|
|
|